CYTOKINETICS Executive Exercises and Sells Stock Options

This Form 4 filing reports transactions by Malik Fady Ibraham, Executive Vice President of Research & Development at CYTOKINETICS INC (CYTK), on April 7, 2026. The executive exercised and sold stock options in two separate transactions. First, he exercised 3,500 options at $7.80 per share and immediately sold the shares at $65.21 per share, resulting in a net sale. Second, he exercised 1,000 options at $10.60 per share and sold them at $64.75 per share. Following these transactions, Ibraham holds 153,902 shares of common stock directly. The transactions represent significant option exercises with immediate sales, suggesting the executive is realizing gains from previously granted equity compensation. The filing indicates the executive continues to maintain substantial ownership in the company post-transactions.